XNCR
XNCR
NASDAQ · Biotechnology

Xencor Inc

$12.13
+0.01 (+0.08%)
As of Mar 22, 10:12 PM ET ·
Financial Highlights (FY 2026)
Revenue
120.94M
Net Income
-254,610,908
Gross Margin
Profit Margin
-210.5%
Rev Growth
-26.2%
D/E Ratio
0.24
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 60.6% 60.6%
Operating Margin -180.0% -162.0% -5.1% -5.6%
Profit Margin -210.5% -200.0% -6.3% -5.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 120.94M 163.92M 205.11M 207.84M
Gross Profit 124.21M 125.86M
Operating Income -217,639,144 -265,485,537 -10,389,491 -11,650,007
Net Income -254,610,908 -310,585,276 -12,900,416 -11,029,247
Gross Margin 60.6% 60.6%
Operating Margin -180.0% -162.0% -5.1% -5.6%
Profit Margin -210.5% -200.0% -6.3% -5.3%
Rev Growth -26.2% -26.2% +24.6% -9.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 78.08M 78.08M 77.39M 67.20M
Total Equity 323.43M 323.43M 595.63M 536.70M
D/E Ratio 0.24 0.24 0.13 0.13
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -204,329,436 -263,096,996 -15,864,221 -15,646,651
Free Cash Flow -6,278,593 -9,889,518